Leerink Swann Upgrades Boston Scientific To Outperform

Analysts at Leerink Swann upgraded

from Market Perform to Outperform. The price target for Boston Scientific has been raised from $15 to $18. Boston Scientific shares have surged 9.78% over the past 52 weeks, while the S&P 500 index has gained 10.22% in the same period. Boston Scientific's shares rose 2.41% to close at $14.03 yesterday.